Global Oncology Drugs Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 155172
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Oncology Drugs will have significant change from previous year. By the most conservative estimates of global Oncology Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 157520 million in 2019. Over the next five years the Oncology Drugs market will register a 10.7% CAGR in terms of revenue, the global market size will reach US$ 236240 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Chemotherapy

Targeted Therapy

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Others

According to the type, the income of chemotherapy is the highest, reaching 51.31% in 2019.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory or Lung Cancer

Others

According to the application, blood cancer has the highest share of revenue, more than 22 percent in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Roche

Celgene

Novartis

Bristol-Myers Squibb

Johnson & Johnson

Merck & Co.

AstraZeneca

Pfizer

Amgen

Eli Lilly

AbbVie

Takeda

Astellas

Ipsen

Sanofi

Bayer

Biogen Idec

Teva

Otsuka

Eisai

Merck KGaA

Gilead Sciences

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oncology Drugs Market Size 2016-2026

2.1.2 Oncology Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Oncology Drugs Segment by Type

2.2.1 Chemotherapy

2.2.2 Chemotherapy

2.2.3 Immunotherapy (Biologic Therapy)

2.2.4 Hormonal Therapy

2.2.5 Others

2.3 Oncology Drugs Market Size by Type

2.3.1 Global Oncology Drugs Market Size CAGR by Type

2.3.2 Global Oncology Drugs Market Size Market Share by Type (2016-2021)

2.4 Oncology Drugs Segment by Application

2.4.1 Blood Cancer

2.4.2 Breast Cancer

2.4.3 Gastrointestinal Cancer

2.4.4 Prostate Cancer

2.4.5 Respiratory or Lung Cancer

2.4.6 Others

2.5 Oncology Drugs Market Size by Application

2.5.1 Global Oncology Drugs Market Size CAGR by Application

2.5.2 Global Oncology Drugs Market Size Market Share by Application (2016-2021)

3 Global Oncology Drugs by Players

3.1 Oncology Drugs Market Size Market Share by Players

3.1.1 Global Oncology Drugs Revenue by Players (2019-2021E)

3.1.2 Global Oncology Drugs Revenue Market Share by Players (2019-2021E)

3.2 Global Oncology Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Oncology Drugs by Regions

4.1 Oncology Drugs Market Size by Regions (2016-2021)

4.2 Americas Oncology Drugs Market Size Growth (2016-2021)

4.3 APAC Oncology Drugs Market Size Growth (2016-2021)

4.4 Europe Oncology Drugs Market Size Growth (2016-2021)

4.5 Middle East & Africa Oncology Drugs Market Size Growth (2016-2021)

5 Americas

5.1 Americas Oncology Drugs Market Size by Country (2016-2021)

5.2 Americas Oncology Drugs Market Size by Type (2016-2021)

5.3 Americas Oncology Drugs Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oncology Drugs Market Size by Region (2016-2021)

6.2 APAC Oncology Drugs Market Size by Type (2016-2021)

6.3 APAC Oncology Drugs Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Oncology Drugs by Country (2016-2021)

7.2 Europe Oncology Drugs Market Size by Type (2016-2021)

7.3 Europe Oncology Drugs Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oncology Drugs by Region (2016-2021)

8.2 Middle East & Africa Oncology Drugs Market Size by Type (2016-2021)

8.3 Middle East & Africa Oncology Drugs Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Oncology Drugs Market Forecast

10.1 Global Oncology Drugs Forecast by Regions (2021-2026)

10.1.1 Global Oncology Drugs Forecast by Regions (2021-2026)

10.1.2 Americas Oncology Drugs Forecast

10.1.3 APAC Oncology Drugs Forecast

10.1.4 Europe Oncology Drugs Forecast

10.1.5 Middle East & Africa Oncology Drugs Forecast

10.2 Americas Oncology Drugs Forecast by Countries (2021-2026)

10.2.1 United States Oncology Drugs Market Forecast

10.2.2 Canada Oncology Drugs Market Forecast

10.2.3 Mexico Oncology Drugs Market Forecast

10.2.4 Brazil Oncology Drugs Market Forecast

10.3 APAC Oncology Drugs Forecast by Region (2021-2026)

10.3.1 China Oncology Drugs Market Forecast

10.3.2 Japan Oncology Drugs Market Forecast

10.3.3 Korea Oncology Drugs Market Forecast

10.3.4 Southeast Asia Oncology Drugs Market Forecast

10.3.5 India Oncology Drugs Market Forecast

10.3.6 Australia Oncology Drugs Market Forecast

10.4 Europe Oncology Drugs Forecast by Country (2021-2026)

10.4.1 Germany Oncology Drugs Market Forecast

10.4.2 France Oncology Drugs Market Forecast

10.4.3 UK Oncology Drugs Market Forecast

10.4.4 Italy Oncology Drugs Market Forecast

10.4.5 Russia Oncology Drugs Market Forecast

10.5 Middle East & Africa Oncology Drugs Forecast by Region (2021-2026)

10.5.1 Egypt Oncology Drugs Market Forecast

10.5.2 South Africa Oncology Drugs Market Forecast

10.5.3 Israel Oncology Drugs Market Forecast

10.5.4 Turkey Oncology Drugs Market Forecast

10.5.5 GCC Countries Oncology Drugs Market Forecast

10.6 Global Oncology Drugs Forecast by Type (2021-2026)

10.8 Global Oncology Drugs Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Oncology Drugs Product Offered

11.1.3 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 Celgene

11.2.1 Celgene Company Information

11.2.2 Celgene Oncology Drugs Product Offered

11.2.3 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Celgene Main Business Overview

11.2.5 Celgene Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Oncology Drugs Product Offered

11.3.3 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Information

11.4.2 Bristol-Myers Squibb Oncology Drugs Product Offered

11.4.3 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Bristol-Myers Squibb Main Business Overview

11.4.5 Bristol-Myers Squibb Latest Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Information

11.5.2 Johnson & Johnson Oncology Drugs Product Offered

11.5.3 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Johnson & Johnson Main Business Overview

11.5.5 Johnson & Johnson Latest Developments

11.6 Merck & Co.

11.6.1 Merck & Co. Company Information

11.6.2 Merck & Co. Oncology Drugs Product Offered

11.6.3 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Merck & Co. Main Business Overview

11.6.5 Merck & Co. Latest Developments

11.7 AstraZeneca

11.7.1 AstraZeneca Company Information

11.7.2 AstraZeneca Oncology Drugs Product Offered

11.7.3 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 AstraZeneca Main Business Overview

11.7.5 AstraZeneca Latest Developments

11.8 Pfizer

11.8.1 Pfizer Company Information

11.8.2 Pfizer Oncology Drugs Product Offered

11.8.3 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Pfizer Main Business Overview

11.8.5 Pfizer Latest Developments

11.9 Amgen

11.9.1 Amgen Company Information

11.9.2 Amgen Oncology Drugs Product Offered

11.9.3 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Amgen Main Business Overview

11.9.5 Amgen Latest Developments

11.10 Eli Lilly

11.10.1 Eli Lilly Company Information

11.10.2 Eli Lilly Oncology Drugs Product Offered

11.10.3 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Eli Lilly Main Business Overview

11.10.5 Eli Lilly Latest Developments

11. AbbVie

11.11.1 AbbVie Company Information

11.11.2 AbbVie Oncology Drugs Product Offered

11.11.3 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 AbbVie Main Business Overview

11.11.5 AbbVie Latest Developments

11.12 Takeda

11.12.1 Takeda Company Information

11.12.2 Takeda Oncology Drugs Product Offered

11.12.3 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Takeda Main Business Overview

11.12.5 Takeda Latest Developments

11.13 Astellas

11.13.1 Astellas Company Information

11.13.2 Astellas Oncology Drugs Product Offered

11.13.3 Astellas Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Astellas Main Business Overview

11.13.5 Astellas Latest Developments

11.14 Ipsen

11.14.1 Ipsen Company Information

11.14.2 Ipsen Oncology Drugs Product Offered

11.14.3 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Ipsen Main Business Overview

11.14.5 Ipsen Latest Developments

11.15 Sanofi

11.15.1 Sanofi Company Information

11.15.2 Sanofi Oncology Drugs Product Offered

11.15.3 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Sanofi Main Business Overview

11.15.5 Sanofi Latest Developments

11.16 Bayer

11.16.1 Bayer Company Information

11.16.2 Bayer Oncology Drugs Product Offered

11.16.3 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Bayer Main Business Overview

11.16.5 Bayer Latest Developments

11.17 Biogen Idec

11.17.1 Biogen Idec Company Information

11.17.2 Biogen Idec Oncology Drugs Product Offered

11.17.3 Biogen Idec Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 Biogen Idec Main Business Overview

11.17.5 Biogen Idec Latest Developments

11.18 Teva

11.18.1 Teva Company Information

11.18.2 Teva Oncology Drugs Product Offered

11.18.3 Teva Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 Teva Main Business Overview

11.18.5 Teva Latest Developments

11.19 Otsuka

11.19.1 Otsuka Company Information

11.19.2 Otsuka Oncology Drugs Product Offered

11.19.3 Otsuka Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.19.4 Otsuka Main Business Overview

11.19.5 Otsuka Latest Developments

11.20 Eisai

11.20.1 Eisai Company Information

11.20.2 Eisai Oncology Drugs Product Offered

11.20.3 Eisai Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.20.4 Eisai Main Business Overview

11.20.5 Eisai Latest Developments

11.21 Merck KGaA

11.21.1 Merck KGaA Company Information

11.21.2 Merck KGaA Oncology Drugs Product Offered

11.21.3 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.21.4 Merck KGaA Main Business Overview

11.21.5 Merck KGaA Latest Developments

11.22 Gilead Sciences

11.22.1 Gilead Sciences Company Information

11.22.2 Gilead Sciences Oncology Drugs Product Offered

11.22.3 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.22.4 Gilead Sciences Main Business Overview

11.22.5 Gilead Sciences Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Oncology Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Chemotherapy

Table 3. Major Players of Targeted Therapy

Table 4. Major Players of Immunotherapy (Biologic Therapy)

Table 5. Major Players of Hormonal Therapy

Table 6. Major Players of Others

Table 7. Oncology Drugs Market Size CAGR by Type (2016-2021) & ($ Millions)

Table 8. Global Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 9. Global Oncology Drugs Market Size Market Share by Type (2016-2021)

Table 10. Oncology Drugs Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 11. Global Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 12. Global Oncology Drugs Market Size Market Share by Application (2016-2021)

Table 13. Global Oncology Drugs Revenue by Players (2019-2021E) & ($ Millions)

Table 14. Global Oncology Drugs Revenue Market Share by Players (2019-2021E)

Table 15. Global Oncology Drugs Key Players Head office and Products Offered

Table 16. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Oncology Drugs Market Size by Regions 2016-2021 & ($ Millions)

Table 20. Global Oncology Drugs Market Size Market Share by Regions 2016-2021

Table 21. Americas Oncology Drugs Market Size by Country (2016-2021) & ($ Millions)

Table 22. Americas Oncology Drugs Market Size Market Share by Country (2016-2021)

Table 23. Americas Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 24. Americas Oncology Drugs Market Size Market Share by Type (2016-2021)

Table 25. Americas Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 26. Americas Oncology Drugs Market Size Market Share by Application (2016-2021)

Table 27. APAC Oncology Drugs Market Size by Region (2016-2021) & ($ Millions)

Table 28. APAC Oncology Drugs Market Size Market Share by Region (2016-2021)

Table 29. APAC Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 30. APAC Oncology Drugs Market Size Market Share by Type (2016-2021)

Table 31. APAC Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 32. APAC Oncology Drugs Market Size Market Share by Application (2016-2021)

Table 33. Europe Oncology Drugs Market Size by Country (2016-2021) & ($ Millions)

Table 34. Europe Oncology Drugs Market Size Market Share by Country (2016-2021)

Table 35. Europe Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 36. Europe Oncology Drugs Market Size Market Share by Type (2016-2021)

Table 37. Europe Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 38. Europe Oncology Drugs Market Size Market Share by Application (2016-2021)

Table 39. Middle East & Africa Oncology Drugs Market Size by Region (2016-2021) & ($ Millions)

Table 40. Middle East & Africa Oncology Drugs Market Size Market Share by Region (2016-2021)

Table 41. Middle East & Africa Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 42. Middle East & Africa Oncology Drugs Market Size Market Share by Type (2016-2021)

Table 43. Middle East & Africa Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 44. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2016-2021)

Table 45. Key and Potential Regions of Oncology Drugs

Table 46. Key Application and Potential Industries of Oncology Drugs

Table 47. Key Challenges of Oncology Drugs

Table 48. Key Trends of Oncology Drugs

Table 49. Global Oncology Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 50. Global Oncology Drugs Market Size Market Share Forecast by Regions

Table 51. Global Oncology Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 52. Global Oncology Drugs Market Size Market Share Forecast by Type (2021-2026)

Table 53. Global Oncology Drugs Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 54. Global Oncology Drugs Market Size Market Share Forecast by Application (2021-2026)

Table 55. Roche Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 56. Roche Oncology Drugs Product Offered

Table 57. Roche Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 58. Roche Main Business

Table 59. Roche Latest Developments

Table 60. Celgene Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 61. Celgene Oncology Drugs Product Offered

Table 62. Celgene Main Business

Table 63. Celgene Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 64. Celgene Latest Developments

Table 65. Novartis Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 66. Novartis Oncology Drugs Product Offered

Table 67. Novartis Main Business

Table 68. Novartis Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 69. Novartis Latest Developments

Table 70. Bristol-Myers Squibb Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 71. Bristol-Myers Squibb Oncology Drugs Product Offered

Table 72. Bristol-Myers Squibb Main Business

Table 73. Bristol-Myers Squibb Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 74. Bristol-Myers Squibb Latest Developments

Table 75. Johnson & Johnson Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 76. Johnson & Johnson Oncology Drugs Product Offered

Table 77. Johnson & Johnson Main Business

Table 78. Johnson & Johnson Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 79. Johnson & Johnson Latest Developments

Table 80. Merck & Co. Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 81. Merck & Co. Oncology Drugs Product Offered

Table 82. Merck & Co. Main Business

Table 83. Merck & Co. Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 84. Merck & Co. Latest Developments

Table 85. AstraZeneca Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 86. AstraZeneca Oncology Drugs Product Offered

Table 87. AstraZeneca Main Business

Table 88. AstraZeneca Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 89. AstraZeneca Latest Developments

Table 90. Pfizer Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 91. Pfizer Oncology Drugs Product Offered

Table 92. Pfizer Main Business

Table 93. Pfizer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 94. Pfizer Latest Developments

Table 95. Amgen Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 96. Amgen Oncology Drugs Product Offered

Table 97. Amgen Main Business

Table 98. Amgen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 99. Amgen Latest Developments

Table 100. Eli Lilly Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 101. Eli Lilly Oncology Drugs Product Offered

Table 102. Eli Lilly Main Business

Table 103. Eli Lilly Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 104. Eli Lilly Latest Developments

Table 105. AbbVie Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 106. AbbVie Oncology Drugs Product Offered

Table 107. AbbVie Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 108. AbbVie Main Business

Table 109. AbbVie Latest Developments

Table 110. Takeda Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 111. Takeda Oncology Drugs Product Offered

Table 112. Takeda Main Business

Table 113. Takeda Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 114. Takeda Latest Developments

Table 115. Astellas Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 116. Astellas Oncology Drugs Product Offered

Table 117. Astellas Main Business

Table 118. Astellas Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 119. Astellas Latest Developments

Table 120. Ipsen Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 121. Ipsen Oncology Drugs Product Offered

Table 122. Ipsen Main Business

Table 123. Ipsen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 124. Ipsen Latest Developments

Table 125. Sanofi Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 126. Sanofi Oncology Drugs Product Offered

Table 127. Sanofi Main Business

Table 128. Sanofi Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 129. Sanofi Latest Developments

Table 130. Bayer Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 131. Bayer Oncology Drugs Product Offered

Table 132. Bayer Main Business

Table 133. Bayer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 134. Bayer Latest Developments

Table 135. Biogen Idec Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 136. Biogen Idec Oncology Drugs Product Offered

Table 137. Biogen Idec Main Business

Table 138. Biogen Idec Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 139. Biogen Idec Latest Developments

Table 140. Teva Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 141. Teva Oncology Drugs Product Offered

Table 142. Teva Main Business

Table 143. Teva Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 144. Teva Latest Developments

Table 145. Otsuka Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 146. Otsuka Oncology Drugs Product Offered

Table 147. Otsuka Main Business

Table 148. Otsuka Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 149. Otsuka Latest Developments

Table 150. Eisai Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 151. Eisai Oncology Drugs Product Offered

Table 152. Eisai Main Business

Table 153. Eisai Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 154. Eisai Latest Developments

Table 155. Merck KGaA Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 156. Merck KGaA Oncology Drugs Product Offered

Table 157. Merck KGaA Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 158. Merck KGaA Main Business

Table 159. Merck KGaA Latest Developments

Table 160. Gilead Sciences Details, Company Type, Oncology Drugs Area Served and Its Competitors

Table 161. Gilead Sciences Oncology Drugs Product Offered

Table 162. Gilead Sciences Main Business

Table 163. Gilead Sciences Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 164. Gilead Sciences Latest Developments

List of Figures

Figure 1. Oncology Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Oncology Drugs Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Oncology Drugs Market Size Market Share by Type (2016-2021)

Figure 7. Oncology Drugs in Blood Cancer

Figure 8. Global Oncology Drugs Market: Blood Cancer (2016-2021) & ($ Millions)

Figure 9. Oncology Drugs in Breast Cancer

Figure 10. Global Oncology Drugs Market: Breast Cancer (2016-2021) & ($ Millions)

Figure 11. Oncology Drugs in Gastrointestinal Cancer

Figure 12. Global Oncology Drugs Market: Gastrointestinal Cancer (2016-2021) & ($ Millions)

Figure 13. Oncology Drugs in Prostate Cancer

Figure 14. Global Oncology Drugs Market: Prostate Cancer (2016-2021) & ($ Millions)

Figure 15. Oncology Drugs in Respiratory or Lung Cancer

Figure 16. Global Oncology Drugs Market: Respiratory or Lung Cancer (2016-2021) & ($ Millions)

Figure 17. Oncology Drugs in Others

Figure 18. Global Oncology Drugs Market: Others (2016-2021) & ($ Millions)

Figure 19. Global Oncology Drugs Market Size Market Share by Application in 2020

Figure 20. Global Oncology Drugs Revenue Market Share by Player in 2020

Figure 21. Global Oncology Drugs Market Size Market Share by Regions (2016-2021)

Figure 22. Americas Oncology Drugs Market Size 2016-2021 ($ Millions)

Figure 23. APAC Oncology Drugs Market Size 2016-2021 ($ Millions)

Figure 24. Europe Oncology Drugs Market Size 2016-2021 ($ Millions)

Figure 25. Middle East & Africa Oncology Drugs Market Size 2016-2021 ($ Millions)

Figure 26. Americas Oncology Drugs Market Size Market Share by Country in 2020

Figure 27. Americas Oncology Drugs Market Size Market Share by Type in 2020

Figure 28. Americas Oncology Drugs Market Size Market Share by Application in 2020

Figure 29. United States Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 30. Canada Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 31. Mexico Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 32. APAC Oncology Drugs Market Size Market Share by Regions in 2020

Figure 33. APAC Oncology Drugs Market Size Market Share by Type in 2020

Figure 34. APAC Oncology Drugs Market Size Market Share by Application in 2020

Figure 35. China Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 36. Japan Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 37. Korea Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 38. Southeast Asia Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 39. India Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 40. Australia Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 41. Europe Oncology Drugs Market Size Market Share by Countries in 2020

Figure 42. Europe Oncology Drugs Market Size Market Share by Type in 2020

Figure 43. Europe Oncology Drugs Market Size Market Share by Application in 2020

Figure 44. Germany Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 45. France Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 46. UK Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 47. Italy Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 48. Russia Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 49. Middle East & Africa Oncology Drugs Market Size Market Share by Region in 2020

Figure 50. Middle East & Africa Oncology Drugs Market Size Market Share by Type in 2020

Figure 51. Middle East & Africa Oncology Drugs Market Size Market Share by Application in 2020

Figure 52. Egypt Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 53. South Africa Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 54. Israel Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 55. Turkey Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 56. GCC Countries Oncology Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 57. Americas Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 58. APAC Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 59. Europe Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 60. Middle East & Africa Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 61. United States Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 62. Canada Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 63. Mexico Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 64. Brazil Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 65. China Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 66. Japan Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 67. Korea Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 68. Southeast Asia Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 69. India Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 70. Australia Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 71. Germany Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 72. France Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 73. UK Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 74. Italy Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 75. Russia Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 76. Spain Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 77. Egypt Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 78. South Africa Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 79. Israel Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 80. Turkey Oncology Drugs Market Size 2021-2026 ($ Millions)

Figure 81. GCC Countries Oncology Drugs Market Size 2021-2026 ($ Millions)